This is the largest screening study of patients referred for testing of genetic causes of ataxia, and assesses the frequency of FXN GAA expansions, point mutations and exonic deletions in patients referred to a tertiary hospital specialist neurogenetics laboratory (at the National Hospital for Neurology and Neurosurgery, London, UK). This evidence concerns the gene FXN and cerebellar ataxia.